Energy metabolism of adriamycin-sensitive and -resistant Ehrlich ascites tumor cells

Oncology Research

Volumn 8, Issue 1, 1996, Pages 27-35

  Miccadei, Stefania ^a   Fanciulli, Maurizio ^a   Bruno, Tiziana ^a   Paggi, Marco G ^a   Floridi, Aristide ^a,b  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

adriamycin; drug resistance; Ehrlich tumor cells; energy metabolism

Indexed keywords

ADENOSINE TRIPHOSPHATE; DOXORUBICIN; LACTIC ACID;

AEROBIC METABOLISM; ANIMAL CELL; ARTICLE; ASCITES TUMOR CELL; CELL RESPIRATION; CITRIC ACID CYCLE; DRUG SENSITIVITY; EHRLICH ASCITES TUMOR; ENERGY METABOLISM; FEMALE; GLYCOLYSIS; MALE; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; OXIDATIVE PHOSPHORYLATION; OXYGEN CONSUMPTION; PENTOSE PHOSPHATE CYCLE; PRIORITY JOURNAL;

EID: 0030009424     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Beck, W. T. The cell biology of multiple drug resistance. Biochem. Pharmacol. 36:2879-2887; 1987.
2. Curt, G. A.; Clendennin, N. J.; Chabner, B. A. Drug resistance in cancer. Cancer Treat. Rep. 68:87-99; 1984.
3. Zijlstra, J. G.; deVries, E. G. E.; Mulder, N. H. Multifactorial drug resistance in an Adriamycin-resistant human small cell lung carcinoma cell line. Cancer Res. 47:1780-1784; 1987.
4. Kartner, N.; Riordan, J. R.; Ling, V. Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines. Science 122:1285-1287; 1983.
5. Giavazzi, R.; Kartner, N.; Hart, I. R. Expression of cell surface P-glycoprotein by an Adriamycin-resistant murine fibrosarcoma. Cancer Chemother. Pharmacol. 13:145-147; 1984.
6. Center, M. S. Mechanisms regulating cell resistance to adriamycin. Biochem. Pharmacol. 34:1471-1476; 1985.
7. Scheper, R. J.; Broxterman, H. J.; Scheffer, G. L.; Meijer, C. J. L. M.; Pinedo, H. M. Drug transporter proteins in clinical multidrug resistance. Clin. Chim. Acta 206:25-27; 1992.
8. Fairchild, C. R.; Ivy, S. P.; Kao-Shan, C. S.; Whang-Peng, J.; Rosen, N.; Israel, M. A.; Malera, P. W.; Cowan, K. H.; Goldsmith, M. E. Isolation of amplified and overexpressed DNA sequences from Adriamycin-resistant human breast cancer cells. Cancer Res. 47:5141-5148; 1987.
9. Warburg, O. On the origin of the cancer cells. Science 123:309-314; 1956.
10. Aisemberg, A. C. The glycolysis and respiration of tumors. New York: Academic Press; 1961.
11. Goldeberg, E. B.; Colowick, S. P. The role of glycolysis in the growth of tumor cells. J. Biol. Chem. 240:2786-2790; 1965.
12. Wu, R. Control mechanisms of glycolysis in Ehrlich ascites tumor cells. J. Biol. Chem. 240:2827-2832; 1965.
13. Nakashima, R. A.; Paggi, M. G.; Pedersen, P. L. Contributions of glycolysis and oxidative phosphorylation to adenosine-5′-triphosphate production in AS-30D hepatoma cells. Cancer Res. 44:5702-5706; 1984.
14. Papacostantinou, J.; Colowick, S. P. The role of glycolysis in the growth of tumor cells. J. Biol. Chem.236:278-288; 1961.
15. Flier, J. S.; Mueckler, M. M.; Usher, P.; Lodish, H. F. Elevated levels of glucose transport and transporter messanger RNA are induced by ras or src oncogenes. Science 235:1492-1498; 1986.
16. Pedersen, P. L. Tumor mitochondria and the bioenergetics of cancer cells. Prog. Exp. Tumor Res. 22:190-274; 1978.
17. Burk, D.; Woods, M.; Hunter, J. On the significance of glycolysis for cancer growth with special reference to Morris hepatomas. J. Natl. Cancer Inst. 38:839-863; 1967.
18. Fanciulli, M.; Paggi, M. G.; Bruno, T.; Del Carlo, C.; Bonetto, F.; Gentile, F. P.; Floridi, A. Glycolysis and growth rate in normal and hexokinase-transfected NIH3T3 cells. Oncol. Res. 6:405-409; 1994.
19. Rose, I. A.; Warms, J. V. B. Mitochondrial hexokinase. Release, rebinding and location. J. Biol. Chem. 242:1635-1645; 1967.
20. Bustamante, E.; Pedersen, P. L. High aerobic glycolysis of rat hepatoma cells in culture: role of mitochondrial hexokinase. Proc. Natl. Acad. Sci. USA 74:3735-3739; 1977.
21. Arora, K. K.; Pedersen, P. L. Functional significance of mitochondrial bound hexokinase in tumor cell metabolism. Evidence for preferential phosphorylation of intramitochondrially generated ATP. J. Biol. Chem. 263:17422-17428; 1988.
22. Nakashima, R. A.; Paggi, M. G.; Pedersen, P. L. Purification and characterization of a bindable form of a mitochondrial bound hexokinase from the higly glycolytic AS-30D rat hepatoma cell line. Cancer Res. 48:913-919; 1988.
23. Lyon, R. C.; Choen, J. S.; Faustino, P. J.; Megnin, F.; Myers, C. E. Glucose metabolism in drug-sensitive and drug-resistant human breast cancer cells monitored by magnetic resonance spectroscopy. Cancer Res. 48:870-877; 1988.
24. Kaplan, O.; Navon, G.; Lyon, R. C.; Faustino, P. J.; Straka, E. J.; Cohen, J. S. Effect of 2-deoxyglucose on drug-sensitive and drug-resistant human breast cancer cells: toxicity and magnetic resonance spectroscopy study of metabolism. Cancer Res. 50:544-551; 1990.
25. Fanciulli, M.; Bruno, T.; Castiglione, S.; Del Carlo, C.; Paggi, M. G.; Floridi, A. Glucose metabolism in adriamycin-sensitive and -resistant LoVo human colon carcinoma cells. Oncol. Res. 5:357-362; 1993.
26. 2 solubility in aqueous media determined by kinetic method. Anal. Biochem. 45:430-450; 1985.
27. Hohorst, H. J. Determination with lactic dehydrogenase and DPN. In: Bergmeyer, H. U., ed. Methods of Enzymatic Analysis. New York: Academic Press; 1965:pp. 266-270.
28. Scott, F.; Fracastoro, A. P.; Taft, E. B. Studies in histochemistry. Determination of nucleic acids in microgram amounts of tissue. J. Histochem. Cytochem. 4:1-10; 1956.
29. 3H compounds. Anal. Biochem. 7:207-214; 1964.
30. Katz, J.; Landau, B. R.; Bartsch, G. E. The pentose cycle, triose phosphate isomerization and lipogenesis in rat adipose tissue. J. Biol. Chem. 241:727-740; 1966.
31. 14C and estimation of the rates of transaldolase, transketolase, the contribution of the pentose cycle, and ribose phosphate synthesis. Biochemistry 6:2227-2247; 1967.
32. Wood, H. G.; Katz, J.; Landau, B. R. Estimation of pathways of carbohydrate metabolism. Biochem. Zeitschrift 338:809-847; 1963.
33. Kaushal, V.; Barnes, L. D. Effect of zwitterionic buffers on measurement of small masses of protein with bicinchoninic acid. Anal. Biochem. 157:291-294; 1986.
34. Board, M.; Humm, S.; Newsholme, E. A. Maximum activities of key enzymes of glycolysis, glutaminolysis, pentose phosphate pathway and tricarboxylic acid cycle in normal, neoplastic and suppressed cells. Biochem. J. 265:503-509; 1990.
35. Parry, D.; Pedersen, P. L. Intracellular localization and properties of particulate hexokinase in the Novikoff ascites tumor. J. Biol. Chem. 258:10904-10912; 1983.
36. Chance, B.; Williams, G. R. Respiratory enzymes in oxidative phosphorylation. III. Kinetics of oxygen utilization. J. Biol. Chem. 217:383-393; 1955.
37. Kaschnitz, R. H.; Hatefy, Y.; Morris, H. P. Oxidative phosphorylation properties of mitochondria isolated from transplanted hepatoma. Biochem. Biophys. Acta 449:224-235; 1976.
38. Chance, B.; Hess, B. Metabolic control mechanism, II. Crossover phenomena in mitochondria of ascites tumor cells. J. Biol. Chem. 234:2413-2415; 1959.
39. Gessner, T.; Vaughan, L. A.; Beehler, B. C.; Bartels, C. J.; Baker, R. M. Elevated pentose cycle and glucuronyltransferase in daunomycin-resistant P388 cells. Cancer Res. 50:3921-3927; 1990.
40. Skovgaard, T. Mechanisms of resistance to daunorubicin in Ehrlich ascites tumor cells. Cancer Res. 38:1785-1791; 1978.
41. Yeh, G. C.; Occhipinti, S. J.; Cowan, K. H.; Chabner, B. A.; Myers, C. E. Adriamycin resistance in human tumor cells associated with marked alterations in the regulation of the hexose monophosphate shunt and its response to oxidant stress. Cancer Res. 47:5994-5999; 1987.
42. Lee, F. Y.; Vassey, A. R.; Sieman, D. W. Glutathione as a determinant of cellular response to doxorubicin. Natl. Cancer Inst. Monogr. 6:211-215; 1988.
43. Russo, A.; Mitchell, J. B. Potentiation and protection of doxorubicin toxicity by cellular glutathione modulation. Cancer Treat. Rep. 69:1293-1296; 1985.
44. Kramer, R. A.; Zacker, J.; Kim, G. Role of glutathione redox cycle in acquired and de novo multidrug resistance. Science 241:694-697; 1988.
45. Nielsen, D.; Maare, C.; Skovsgaard, T. Influx of daunorubicin in multidrug resistant Ehrlich ascites tumor cells: correlation to expression of P-glycoprotein and efflux. Influence of verapamil. Biochem. Pharmacol. 50:443-450; 1995.
46. Nielsen, D.; Maare, C.; Skovsgaard, T. Kinetics of daunorubicin transport in Ehrlich ascites tumor cells with different expression of P-glycoprotein. Biochem. Pharmacol. 47:2125-2135; 1994.
47. Stein, W. D.; Cardarelli, C.; Pastan, I.; Gottesman, M. M. Kinetic evidence suggesting that the multidrug transporter differentially handles influx and efflux of its substrates. Mol. Pharmacol. 45:763-772; 1994.
48. Floridi, A.; Paggi, M. G.; Marcante, M. L.; Silvestrini, B.; Caputo, A.; De Martino, C. Lonidamine, a selective inhibitor of aerobic glycolysis of murine tumor cells. J. Natl. Cancer Inst. 66:497-499; 1981.
49. Floridi, A.; Paggi, M. G.; D'Atri, S.; De Martino, C.; Marcante, M. L.; Silvestrini, B.; Caputo, A. Effect of lonidamine on the energy metabolism of Ehrlich ascites tumor cells. Cancer Res. 41:4661-4666; 1981.
50. Floridi, A.; Lehninger, A. L. Action of the antitumor and antispermatogenic agent lonidamine on electron transport in Ehrlich ascites tumor mitochondria. Arch. Biochem. Biophys. 226:73-83; 1983.
51. Santini, M. T.; Cametti, C.; Indovina, P. L.; Malomi, W.; Benassi, M.; Gentile, F. P.; Castiglione, S.; Floridi, A. Effects of lonidamine on the membrane electrical properties of Ehrlich ascites tumor cells. FEBS Lett. 291:196-172; 1991.
52. Raaphorst, G. P.; Feeley, M. M.; Heller, D. P.; Danjoux, C. E.; Martin, L.; Maroun, J. A.; De Santis, A. J. Lonidamine can enhance the cytotoxic effect of cisplatin in human tumor cells and in rodent cells. Anticancer Res 10:923-928; 1990.
53. Floridi, A.; Gentile, F. P.; Bruno, T.; Fanciulli, M.; Paggi, M. G.; Zeuli, M.; Benassi, M. Cytotoxic effect of the association of BCNU with rhein or lonidamine on a human glioma cell line. Anticancer Res. 11:789-792; 1991.
54. Floridi, A.; Gambacurta, A.; Bagnato, A.; Bianchi, C.; Paggi, M. G.; Silvestrini, B.; Caputo, A. Modulation of adriamycin uptake by lonidamine in Ehrlich ascites tumor cells. Exp. Mol. Pathol. 49:421-431; 1988.
55. Citro, G.; Cucco, C.; Verdina, A.; Zupi, G. Reversal of adriamycin resistance by lonidamine in a human breast cancer cell line. Br. J. Cancer 64:534-536; 1991.